-
November 6, 2017 •
Business Focus, Capital markets/Funding, Feature Slider, Feature-Home, Featured-Slides-Home, Sales/Marketing •
455
Two years after buying a company that manufacturers female libido pills for $1 billion, Valeant Pharmaceuticals International...
-
June 30, 2017 •
Feature, Opinions, Sales/Marketing •
655
The Ontario Brain Institute (OBI) boasts a healthy portfolio of 56 companies that we support as part of our strategic mandate to...
-
May 30, 2017 •
Business Focus, Deals/M&A/Collaboration, Feature Slider, Feature-Home, Featured-Slides-Home, Sales/Marketing •
798
If you were ever in search any more indications that the local cannabis market is smoking, this just might be it. The iconic...
-
May 19, 2017 •
Business Focus, Deals/M&A/Collaboration, Sales/Marketing •
392
Vancouver’s Novelogics Biotechnology Inc., has signed a research agreement with Canada’s national drug development and...
-
May 8, 2017 •
Business Focus, Capital markets/Funding, Feature Slider, Featured-Slides-Home, Health, Podcast, Sales/Marketing •
719
Biotechnology Focus was at the sixth annual Bloom Burton & Co. Healthcare Investor Conference in downtown Toronto. More than...
-
May 5, 2017 •
Business Focus, Clinical Trials, Feature Slider, Feature-Home, Featured-Slides-Home, Health Care, Sales/Marketing •
308
Earlier this week, Toronto’s Merus Labs International said it has received regulatory approval to sell its blood...
-
May 1, 2017 •
Business Focus, Capital markets/Funding, Feature Slider, Feature-Home, Featured-Slides-Home, Policy/Regulatory/IP, Sales/Marketing •
231
Valeant Pharmaceuticals today announced that a couple of financial developments is making helping the Laval, Que.-based pharma...
-
April 19, 2017 •
Bio-Medical, Business Focus, Clinical Trials, Drug Development, Feature Slider, Health, Health Care, Oncology, Sales/Marketing •
440
Health Canada has approved with conditions the immunotherapy drug, Tecentriq, for the treatment of patients with locally advanced...
-
March 13, 2017 •
Business Focus, Sales/Marketing, Uncategorized •
511
MONTREAL, QC -Canadian specialty pharmaceutical company Knight Therapeutics Inc. has commercially relaunched MOVANTIK, a...
-
March 6, 2017 •
Business Focus, Feature, Sales/Marketing •
465
TORONTO, ON- Antibe Therapeutics Inc. reports it has signed an exclusive licensing and distribution agreement with a...